“Solanki identifies a strategic play in the Pharma sector around upcoming generic drug launches in March (India) and April (Canada), despite expected initial price erosion. He recommends Emcure Pharmaceuticals for the drug side and Shaily Engineering and Plastics, which manufactures injector pens, to capitalize on this event in the near term.”

Narendra Solanki’s track record: 9 graded calls · 95% CI 6–55%